Show
Sort by
-
The distress thermometer predicts subjective, but not objective, cognitive complaints six months after treatment initiation in cancer patients
-
Validation of the Freund Clock Drawing Test as a screening tool to detect cognitive dysfunction in elderly cancer patients undergoing comprehensive geriatric assessment
-
Validation of the Freund Clock Drawing Test as a screening tool to detect cognitive dysfunction in elderly cancer patients undergoing comprehensive geriatric assessment
-
Preoperative chemosensitivity testing as predictor of adjuvant benefit in stage III colon
-
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digstive Oncology
-
A phase II randomized study of combined infusional leucovorin sodium and 5-FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer
-
- Conference Paper
- C3
- open access
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study
-
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
-
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study
-
Mucosal healing predicts sustained clinical remission in early Crohn's disease